SCHEMBL29637247

SCHEMBL29637247

CC(C)(C)CC(C)(C)c1ccc(O)c(N=Nc2ccccc2[N+](=O)[O-])c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
PTPN11 Q06124 7/20 0.44
PTPN1 P18031 2/20 0.43
PTPN6 P29350 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
HPGD P15428 1/20 0.43
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
HIF1A Q16665 1/20 0.41
CCNT1 O60563 1/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
CDK1 P06493 1/20 0.39
CDK4 P11802 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNA2 P20248 1/20 0.39
CCND1 P24385 1/20 0.39
CCNE1 P24864 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6867726 1.00 NPC1 (0.45) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL6867724 1.00 NPC1 (0.45) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9460754 0.91 PTPN11 (0.40) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9460749 0.91 PTPN11 (0.40) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9183429 0.89 NPC1 (0.46) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9183427 0.89 NPC1 (0.46) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL7698052 0.88 PTPN11 (0.40) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL7575141 0.88 PTPN11 (0.40) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9182266 0.86 GAA (0.50) NPC1RAB9APTPN11PTPN1PTPN6
SCHEMBL9182261 0.86 GAA (0.50) NPC1RAB9APTPN11PTPN1PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119661455-A Preparation method and application of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 湖北美峰技术开发有限公司 2025-03-21 CN claimed
CN-116375599-A Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2023-07-04 CN claimed
CN-115850197-A Preparation method of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 利安隆科润(浙江)新材料有限公司 2023-03-28 CN claimed
CN-116375599-B Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2025-11-11 CN disclosed
CN-116375599-B Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2025-11-11 CN disclosed
US-12319661-B2 Polycyclic compound EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) 2025-06-03 US disclosed
CN-119661455-A Preparation method and application of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 湖北美峰技术开发有限公司 2025-03-21 CN disclosed
CN-115608398-B M-N-C catalyst and application thereof in synthesis of benzotriazole compounds 天津大学 2024-04-30 CN disclosed
CN-116375599-A Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2023-07-04 CN disclosed
CN-116375599-A Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2023-07-04 CN disclosed
CN-116375599-A Method for preparing 2-nitro-2 '-hydroxy-5' -tert-octyl azobenzene in aqueous medium system 天津城建大学 2023-07-04 CN disclosed
CN-115850197-A Preparation method of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 利安隆科润(浙江)新材料有限公司 2023-03-28 CN disclosed
CN-115850197-A Preparation method of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 利安隆科润(浙江)新材料有限公司 2023-03-28 CN disclosed
CN-115608398-A M-N-C catalyst and application thereof in synthesis of benzotriazole compounds 天津大学 2023-01-17 CN disclosed
CN-114213348-A Method for continuous flow synthesis of 2- (2 '-hydroxy-5' -tert-octylphenyl) benzotriazole 宿迁联盛科技股份有限公司 2022-03-22 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12319661-B2 Polycyclic compound CUTA, CDH1, DSG1 NPC1 4112/4885RAB9A 3272/4885PTPN11 4481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.